Aetna shareholders seek alternatives to split:
This article was originally published in Clinica
Executive Summary
Aetna, the largest health insurer in the US, may not now split from the remainder of the group as institutional shareholders are looking at a way of keeping the health and the financial services businesses of Aetna together. Last month a Dutch insurer, ING, and the US health insurer, WellPoint, offered $70 a share for the whole group (see Clinica No 900, p 12). While this was a massive premium on the company's then $40 share price, the bid was rejected and Aetna's board proposed the split. Investors are seeking ways to get the share price back to its $100-plus high point.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.